[Evaluation of the therapeutic effectiveness of Falepsin (P 845) in the treatment of epileptic seizures].
D000293:Adolescent; D000328:Adult; D000605:Amino Alcohols / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004361:Drug Tolerance; D004569:Electroencephalography; D004832:Epilepsy, Absence / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D006801:Humans; D008875:Middle Aged; D010627:Phenethylamines / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use*; D013997:Time Factors
D000605:Amino Alcohols; D000927:Anticonvulsants; D010627:Phenethylamines; D010634:Phenobarbital
Ocena skuteczności leczniczej preparatu Falepsin (P 845) u chorych z napadami padaczkowymi.